Mayne Pharma Group Ltd (ASX:MYX)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MYX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MYX

  • Market CapAUD0.000m
  • SymbolASX:MYX
  • IndustryHealthcare
  • Sector-
  • Currency
  • ISINAU000000MYX0

Company Profile

Mayne Pharma is a small generics and specialty pharmaceutical manufacturer that earns over 90% of revenue in the U.S. market. Product portfolios focus on dermatology and women’s health. The company performs very limited research and development, typically acquiring off-patent or tail-end brands. In fiscal 2019 generics contributed 61% of revenue and specialty brands 17%, with the balance coming from non-U.S. sales and contract manufacturing. Dynamics within the U.S. generics market leading to increased competition and significant drug price declines have resulted in Mayne significantly impairing acquired intangible assets. The company is shifting its focus to growth of the higher-margin specialty brands segment.Mayne Pharma Group Ltd is a specialty pharmaceutical company. It develops, manufactures and markets branded and generic products. It has two drug development and manufacturing facilities based in Salisbury, South Australia, North Carolina and U.S.A.

Latest MYX news

Currently there for this company. Visit our news hub for other news .